Serial Number
99311084
Owner
POPVAX PRIVATE LIMITEDAttorney
Jonathan M. RixenFiling Date
Jul 30, 2025
TEZ BIO Trademark
Serial Number: 99311084
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Jonathan M. Rixen Dennemeyer & Associates, LLC
230 W. Monroe St.
Suite 2100
Chicago, IL 60606
United States
Trademark Details
Filing Date
July 30, 2025
Registration Date
Not Registered
Published for Opposition
March 10, 2026
Goods & Services
Biological research; medical research; scientific laboratory services; scientific research; chemical research; research and development of new products for others; technological research in the field of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, and biosimilars; scientific, medical, biological research and development in the field of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, and biosimilars; conducting clinical trials for others and testing services in the field of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, and biosimilars; engineering services relating to research and development of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, and biosimilars; software as a service (SaaS) services featuring computer software for designing, modelling, analysis, data analysis, data management, modification, prediction, and optimization of structure, function, sequence, dynamics, stability, and thermodynamics of nucleic acids, polynucleotides, oligonucleotides, proteins, antigens, immunogens, antibodies, nanobodies, drug conjugates, ligands, peptides, amino acids, nucleotides, nucleosides, carbohydrates, adjuvants, drug delivery carriers, lipids, polymers and formulations for use in manufacturing of pharmaceutical, vaccines, medicines, biologics, biotherapeutics, and biosimilars; creation of websites for others featuring information in the pharmaceutical, medical and health fields; hosting of a website featuring information in the pharmaceutical, medical and health fields; hosting podcasts in the field of pharmaceuticals, vaccines, medicines, biologics, biotherapeutics, and biosimilars; software as a service (SaaS) services featuring computer software for designing, modelling, analysis, data analysis, data management, modification, prediction, and optimization of structure, function, sequence, dynamics, stability, and thermodynamics of nucleic acids, polynucleotides, oligonucleotides, proteins, antigens, immunogens, antibodies, nanobodies, drug conjugates, ligands, peptides, amino acids, nucleotides, nucleosides, carbohydrates, adjuvants, drug delivery carriers, lipids, polymers, and formulations; software as a service (saas) services featuring computer software for use in designing, modelling, analysis, data analysis, data management, modification, prediction, and optimization of experiments related to molecular biology, cell biology, biochemistry, organic chemistry, inorganic chemistry, biophysics, immunology, sequencing, toxicology, pharmacodynamics, pharmacokinetics, biodistribution, formulation, drug delivery, bioassays, analytical assays, and analytical characterization for production or manufacturing of pharmaceutical and biopharmaceutical preparations, data management, or clinical trial management
Providing private equity and investment funding; venture capital services, namely, providing financing to emerging companies, start-up companies, small businesses, developing companies, and late-stage companies and entrepreneurs; venture capital funding services to emerging companies, start-up companies, small businesses, developing companies, and late-stage companies and entrepreneurs; venture capital funding services to pharmaceutical companies, biotechnology companies, vaccine companies, chemical companies, medical devices companies, diagnostic companies, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), clinical research companies, software companies, and hardware companies; providing working capital financing to businesses and business owners, namely, emerging and start-up companies; providing working capital financing to pharmaceutical companies, biotechnology companies, vaccine companies, chemical companies, medical devices companies, diagnostic companies, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), clinical research companies, software companies, and hardware companies; providing venture capital, development capital, private equity and investment funding to emerging companies, start-up companies, small businesses, developing companies, and late-stage companies and entrepreneurs; providing venture capital, development capital, private equity and investment funding to pharmaceutical companies, biotechnology companies, vaccine companies, chemical companies, medical devices companies, diagnostic companies, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), clinical research companies, software companies, and hardware companies; providing funding for joint ventures in the field of biological research, medical research, chemical research, pharmaceuticals, nutraceuticals, reagents, chemicals, enzymes, medical devices, biopharmaceuticals, vaccines, biologics, biotherapeutics, and biosimilars; providing funding for inventions in the field of biological research, medical research, chemical research, pharmaceuticals, nutraceuticals, reagents, chemicals, enzymes, medical devices, biopharmaceuticals, vaccines, biologics, biotherapeutics, and biosimilars; providing funding for research, development, and commercialization of products and services in the field of biological research, medical research, chemical research, pharmaceuticals, nutraceuticals, reagents, chemicals, enzymes, medical devices, biopharmaceuticals, vaccines, biologics, biotherapeutics, and biosimilars; providing project grants for research, development, and commercialization of products and services in the field of biological research, medical research, chemical research, pharmaceuticals, nutraceuticals, reagents, chemicals, enzymes, medical devices, biopharmaceuticals, vaccines, biologics, biotherapeutics, and biosimilars; equity capital investment; loan financing of business ventures; creation and management of venture capital investment funds that invest in emerging companies, start-up companies, small businesses, developing companies, and late-stage companies, and entrepreneurs; creation and management of venture capital investment funds that invest in pharmaceutical companies, biotechnology companies, vaccine companies, chemical companies, medical devices companies, diagnostic companies, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), clinical research companies, software companies, and hardware companies